C2,5′-disubstituted and N 6...

Details C2,5′-disubstituted and N 6... C2,5′-disubstituted and N 6...

2007-03-13

2007-03-13

Jiang, S. Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S027230, C536S027620, C536S027630

Reexamination Certificate

active

10653464

ABSTRACT:
The present invention concerns novel C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and their different uses. These adenosine derivatives were found to be potent adenosine receptor agonists and thus are of a therapeutic value in the treatment and prophylaxis of diseases and disorders affected by adenosine receptor agonists.

REFERENCES:
patent: 4357324 (1982-11-01), Montgomery et al.
patent: 5189027 (1993-02-01), Miyashita et al.
patent: 5278150 (1994-01-01), Olsson et al.
patent: 5589467 (1996-12-01), Lau et al.
patent: 5998388 (1999-12-01), Ellis et al.
patent: 5998423 (1999-12-01), Manneth et al.
patent: 6407076 (2002-06-01), Box et al.
patent: 6576620 (2003-06-01), Belardinelli et al.
patent: 6605597 (2003-08-01), Zablocki et al.
patent: WO 97/33591 (1997-09-01), None
patent: WO 98/15276 (1998-04-01), None
patent: WO 99/24450 (1999-05-01), None
patent: WO 99/38877 (1999-08-01), None
patent: WO 99/38877 (1999-08-01), None
patent: WO 00/23457 (2000-04-01), None
patent: WO 00/72799 (2000-12-01), None
van Tilburg et al., “N6,5′-Disubstituted Adenosine Derivatives as Partial Agonists for the Humans Adenosine A3 Receptor,” Journal of Medicinal Chemistry, 42(8), 1393-1400 (1999); Web published Mar. 31, 1999.
Patten et al., “Mutation in the Gene Encoding the Stimulatory G Protein of Adenylate Cyclase in AlbrightÕs Hereditary Osteodystrophy,” The New England Journal of Medicine, 322(20), 1412-1419 (May 17, 1990).
Delgado et al., “Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase—Activating Polypeptide Enhance IL-10 Production by Murine Macrophages: In Vitro and In Vivo Studies,” The Journal of Immunology, 162, 1707-1716 (1999).
Ohm et al., “Reduced Basal and Stimulated (Isoprenaline, Gpp(NH)p, Forskolin) Adenylate Cyclase Activity in AlzheimerÕs Disease Correlated with Histopathological Changes,” Brain Research, 540, 229-236 (1991).
Kozlik-Feldmann et al., “Distribution of Myocardial Beta-Adrenoceptor Subtypes and Coupling to the Adenylate Cyclase in Children with Congenital Heart Disease and Implications for Treatment,” The Journal of Clinical Pharmacology, 33, 588-595 (1993).
van Tilburg et al., “N6,5′-Disubstituted Adenosine Derivatives as Partial Agonists for the Humans Adenosine A3Receptor,”Journal of Medicinal Chemistry, 42(8), 1393-1400 (1999); Web published Mar. 31, 1999.
Patten et al., “Mutation in the Gene Encoding the Stimulatory G Protein of Adenylate Cyclase in Albright's Hereditary Osteodystrophy,” Copy of pubmed abstract supplied by applicant.The New England Journal of Medicine, 322(20), 1412-1419 (May 17, 1990).
Delgado et al., “Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase—Activating Polypeptide Enhance IL-10 Production by Murine Macrophages:In VitroandIn VivoStudies,” Copy of pubmed abstract supplied by applicant.The Journal of Immunology, 162, 1707-1716 (1999), Month of publication data could not be determined from the copy in hand. Issue No. information is provided whenever possible following the vol. No. in parentheses.
Ohm et al., “Reduced Basal and Stimulated (Isoprenaline, Gpp(NH)p, Forskolin) Adenylate Cyclase Activity in Alzheimer's Disease Correlated with Histopathological Changes,” Copy of pubmed abstract supplied by applicant.Brain Research, 540, 229-236 (1991), Month of publication data could not be determined from the copy in hand. Issue No. information is provided whenever possible following the vol. No. in parentheses.
Kozlik-Feldmann et al., “Distribution of Myocardial Beta-Adrenoceptor Subtypes and Coupling to the Adenylate Cyclase in Children with Congenital Heart Disease and Implications for Treatment,” Copy of pubmed abstract supplied by applicant.The Journal of Clinical Pharmacology, 33, 588-595 (1993), Month of publication data could not be determined from the copy in hand. Issue No. information is provided whenever possible following the vol. No. in parentheses.
Bruns, R., “Adenosine Receptor Activation in Human Fibroblasts: Nucleoside Agonists and Antagonists”, Can. J. Physiol. Pharmacol. 1980, 58: 673-691.
Chiang, et al., “S-Adenosyl-L- hemocysteine Hydrolase: Analogues of S-Adenosyl-L-homocysteine as Potential Inhibitors”, Molecular Pharmacology. 1977, vol. 13, 939-947.
Cristalli, et al., “2-Alkynel Derivatives of Adenosine and Adenosine-5′-N-ethyluronamide as Selective Agonists at A2Adenosine Receptors”, J. Med. Chem. 1992, vol. 35, 2363-2368.
Cristalli, et al., “Characterization of Potent Ligands at Human Recombinant Adenosine Receptors”, Drug Development Research. 1998, vol. 45, 176-181.
Daly, et al., “Agonist Activity of 2- and 5′-substituted Adenosine Analogs and Their N6-Cycloalkyl Derivatives at A1-and A2-Adenosine Receptors Coupled to Adenylate Cyclase”, Biochemical Pharmacology, vol. 43 No. 5, 1089-1093.
Gallo-Rodriguez, et al., “Structure-Activity Relationships of N6-Benzyladenosine-5′-uronamides as A3-Selective Adenosine Agonists”, J. Med. Chem. 1994, vol. 37, 636-646. (Published in ACS Abstracts on Jan. 15, 1995).
Hutchinson, et al., “2-(Arylalkylamino)adenosine-5′-uronamides: A New Class of Highly Selective Adenosine A2Receptor Ligands”, J. Med. Chem. 1990, vol. 33, 1919-1924.
Xlotz, et al., “2-Substituted N-ethylcarboxamidoadenosine Derivatives as High-affinity Agonists at Human A3Adenosine Receptors”, Naunyn-Schmiedeberg's Arch Pharmacol. 1999, vol. 360, 103-108. Published online on Jul. 13, 1999.
Roelen, et al., “N6, C8-Disubstituted Adenosine Derivatives as Partial Agonists for Adenosine A1Receptors”, J. Med. Chem. 1996, vol. 39, 1463-1471. Published in ACS Abstracts on Feb. 15, 1996.
van Tilburg, et al., “2,5′-Disubstituted Adenosine Derivatives: Evaluation of Selectivity and Efficacy for the Adenosine A1, A2Aand A3Receptor”, J. Med. Chem. 2002, vol. 45, 420-429. WEB published on Dec. 19, 2001.
van Tilburg, et al., “5′-O-Alkyl Ethers of N,2-Substituted Adenosine Derivatives: Partial Agonists for the Adenosine A1and A3Receptor”, J. Med. Chem. 2001, vol. 44, 2966-2975. WEB published on Jul. 26, 2001.
van Tilburg, et al., “N6,5′-Disubstituted Adenosine Derivatives as Partial Agonists for the Human Adenosine A3Receptor”, J. Med. Chem. Apr. 22, 1999; vol. 42(8), 1393-1400.
Volpini, et al., “Synthesis of Di- and Tri-Substituted Adenosine Derivatives and Their Affinities at Human Adenosine Receptor Subtypes”, Nucleosides & Nucleotides. 1999, vol. 18(11&12), 2511-2520.
Homma, Hiroshi et al “Nucleosides and Nucleotides. 112. 2-(1-Hexyn-1-y1)adenosine-5′-uronamides: A New Entry of Selective A2Adenosine Receptor Agonists with Potent Antihypertensive Activity” J. Med. Chem. (1992) vol. 35 pp.: 2881-2890.
Matsuda, Akira et al “Nucleosides and Nucleotides. 103. 2-Alkynyladenosines: A Novel Class of Selective Adenosine A2Receptor Agonists with Potent Antihypertensive Effects” J. Med. Chem. (1992) vol. 35 pp.: 241-252.
Niiya, Kazunori “2-(N′-Alkylidenehydrazino)adenosines: Potent and Selective Coronary Vasodilators” J. Med. Chem. (1992) vol. 35 pp.: 4557-4561.
van der Wenden, Eleonora M. et al “5′-Substituted Adenosine Analogs as New High-Affinity Partial Agonist for the Adenosine A1Receptor” J. Med. Chem. (1998) vol. 41 pp.: 102-108.
Vittori, Sauro et al “2-Alkenyl and 2-Alkyl Derivatives of Adenosine and Adenosine-5′-N-Ethyluronamide: Different Affinity and Selectivity of E- and Z-Diastereomers at A2AAdenosine Receptors” J. Med. Chem (1996) vol. 39 pp.: 4211-4217.

Affiliated with

Also associated with

Rating

C2,5′-disubstituted and N 6... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C2,5′-disubstituted and N 6..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C2,5′-disubstituted and N 6... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3734682